Cremaschi, Liana, von Versen, Regina, Benzing, Thomas, Wiesener, Michael, Zink, Nikolai, Milkovich, Gary, Paivanas, Thomas, Gallagher, Meghan and Thaiss, Friedrich (2017). Induction therapy with rabbit antithymocyte globulin versus basiliximab after kidney transplantation: a health economic analysis from a German perspective. Transpl. Int., 30 (10). S. 1011 - 1020. HOBOKEN: WILEY. ISSN 1432-2277

Full text not available from this repository.

Abstract

A health economic analysis was undertaken based on the 1-year database from a randomized study of rabbit anti-human thymocyte immunoglobulin (rATG) versus basiliximab, in kidney transplantation using resource utilization data and cost estimates from three German hospitals. A three-state Markov model was applied to estimate cost-effectiveness to 10 years post-transplant. Total mean treatment cost per patient to year 1 post-transplant was Euro62 075 vs. Euro59 767 for rATG versus basiliximab (P < 0.01). rATG therapy was associated with similar treatment costs to basiliximab by year 2, and a predicted cumulative treatment cost saving of Euro4 259 under rATG versus basiliximab by year 10 post-transplant. The mean number of quality-adjusted life years (QALYs) per patient by year 1 was 0.809 vs. 0.802 in the rATG and basiliximab cohorts, respectively (P = 0.38), with cumulative QALYs of 6.161 and 6.065 per patient by year 10. By year 2, the cumulative cost per QALY was slightly lower under rATG (Euro35 378) than basiliximab (Euro35 885), progressing to a saving of Euro1 041 under rATG for the cumulative cost per QALY by year 10. In conclusion, this model indicates that rATG induction provides a modest increase in QALYs with lower long-term costs than basiliximab in deceased-donor high-risk kidney transplant patients.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Cremaschi, LianaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von Versen, ReginaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Benzing, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wiesener, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zink, NikolaiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Milkovich, GaryUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Paivanas, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gallagher, MeghanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Thaiss, FriedrichUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-216278
DOI: 10.1111/tri.12991
Journal or Publication Title: Transpl. Int.
Volume: 30
Number: 10
Page Range: S. 1011 - 1020
Date: 2017
Publisher: WILEY
Place of Publication: HOBOKEN
ISSN: 1432-2277
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
RENAL-ALLOGRAFT RECIPIENTS; COST-EFFECTIVENESS ANALYSIS; ACUTE CELLULAR REJECTION; IMMUNOSUPPRESSIVE THERAPY; SIMULECT; ADULTSMultiple languages
Surgery; TransplantationMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/21627

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item